Abstract:BACKGROUND:Improving poorly soluble drugs into druggability was a major problem faced by pharmaceutists. Nanosuspension can improve the druggability of insoluble drugs by improving the solubility, chemical stability and reducing the use of additives, which provided a new approach for the development and application of the insoluble drugs formulation. Paclitaxel (PTX) is a well-known BCS class IV drug with poor solubility and permeability. Also, many studies have proved that paclitaxel is a substrate of the membrane-bound drug efflux pump P-glycoprotein (P-gp), therefore it often shows limited efficacy against the resistant tumors and oral absorption or uptake. OBJECTIVE:To manufacture an enhanced-penetration PTX nanosuspension (PTX-Nanos), and evaluate the physicochemical property, pharmacokinetics and tissue distribution in vivo and cytotoxic effect in vitro. METHODS:PTX-Nanos were prepared by microprecipitation-high pressure homogenization, with a good biocompatibility amphiphilic block copolymer poly(L-phenylalanine)-b-poly(L-aspartic acid) (PPA-PAA) as stabilizer. RESULTS:The PTX-Nanos had a sustained-dissolution manner and could effectively reduce plasma peak concentration and extend plasma circulating time as compared to PTX injection, markedly passively targeting the MPS-related organs, such as liver and spleen. This unique property might enhance treatment of cancer in these tissues and reduce the side effects in other normal tissues. Moreover, the hybrid stabilizers could enhance penetration of PTX in PTX-Nanos to multidrug resistance cells. CONCLUSION:To sum up, our results showed that the optimal formula could improve the solubility of PTX and the stability of the product. The PTX-Nanos developed in this research would be a promising delivery platform in cancer treatment.

Preparation and evaluation of a Rubropunctatin-loaded liposome anticancer drug carrier

Carboxymethyl Dextran-Stabilized Polyethylenimine-Poly(Epsilon-Caprolactone) Nanoparticles-Mediated Modulation of Microrna-34a Expression Via Small-Molecule Modulator for Hepatocellular Carcinoma Therapy

Preparation, Characterization, and Anti-Tumor Property of Podophyllotoxin-Loaded Solid Lipid Nanoparticles

Enhanced Drug Delivery Using Sonoactivatable Liposomes with Membrane-Embedded Porphyrins

Preparation and characterization of Keratin-PEG conjugate-based micelles as a tumor microenvironment-responsive drug delivery system

Multi‐responsive co‐assembled polyurethane nanomicelles as anticancer drug delivery carriers

[Evaluation for preparation and anticancer efficacy in vitro of drug-loaded nanoerythrosomes].

Enzymatic PEG-Poly(amine-co-disulfide ester) Nanoparticles as pH- and Redox-Responsive Drug Nanocarriers for Efficient Antitumor Treatment

Synthesis and Evaluation of Targeted Nanomicelle Delivery System with Rhein As the Hydrophobic End and Its Synergistic Therapy Effect on Tumor

Design optimization of Fucoidan-coating Cationic Liposomes for enhance Gemcitabine delivery

Lipid-assisted PEG- b-PLA nanoparticles with ultrahigh SN38 loading capability for efficient cancer therapy

Pulmonary delivery of liposomes co-loaded with SN38 prodrug and curcumin for the treatment of lung cancer

Preparation and Evaluation of a Novel Anticancer Drug Delivery Carrier for 5-Fluorouracil Using Synthetic Bola-Amphiphile Based on Lysine As Polar Heads.

Acetalized starch-based nanoparticles stabilized acid-sensitive Pickering emulsion as a potential antitumor drug carrier

Preparation of an Amphiphilic Peptide (P13) with Proton Sponge Effect and Analysis of Its Antitumor Activity

Preparation and Evaluation of Oral Lymphatic Absorption of Probucol-Loaded Micelle Delivery System

Microfluidic Fabrication of Oleosin-Coated Liposomes as Anticancer Drug Carriers with Enhanced Sustained Drug Release

Formulation, Pharmacokinetic Evaluation and Cytotoxicity of an Enhanced- penetration Paclitaxel Nanosuspension.

Preparation and in Vitro Cellular Uptake Assessment of Multifunctional Rubik-Like Magnetic Nano-Assemblies

Increased Delivery of Doxorubicin into Tumor Cells Using Extracellularly Activated Tat Functionalized Liposomes: in Vitro and in Vivo Study

Preparation and Evaluation of Lipid-Matrix Nanocarrier Co-Delivery Gene and Sensibilizer to Elevate Docetaxel Antitumor